Search - tctmd.com

Displaying 861 - 879 of 879

Sort: Relevancy | Date

News Industry News

FDA Advisory Panel to Review Edwards SAPIEN Valve on July 20

June 07, 2011

News Daily News

PARTNER Finds Higher Rate of Neurological Events with TAVI vs. Surgery

L.A. McKeown

May 13, 2011

News Daily News

Single-Center Experience Shows Evolution of CoreValve Procedure Over Time

Jason Kahn

April 18, 2011

News Daily News

TAVI with CoreValve Effective, Safe at 2-Years, Though Mortality a Concern

Leah Lawrence

April 11, 2011

News Conference News

ACC Scientific Session-i2 Summit 2011: The Devil Is in the Details

Caitlin E. Cox

April 08, 2011

News Conference News

Study Focuses on Permanent Pacemaker Predictors in TAVI vs. Surgery

Jason Kahn

April 05, 2011

News Industry News

REMEDIAL II Trial of PLC's RenalGuard® Demonstrates Greater Efficacy than Current Standard of Care

April 04, 2011

News Conference News

PARTNER: TAVI Cost Effective Compared With Standard Care

Jason Kahn

April 03, 2011

News Conference News

PARTNER: In High-Risk Surgical Candidates, TAVI Proves Just as Effective

Caitlin E. Cox

April 03, 2011

News Industry News

Edwards Lifesciences Achieves Primary Endpoint in Transcatheter Valve Study of High-Risk Surgical Patients

April 03, 2011

News Daily News

ESC: Newer Risk Scores May Be Needed for Predicting Mortality in Valve Disease

L.A. McKeown

March 18, 2011

News Daily News

Different Factors Linked to Early, Late Mortality with CoreValve TAVI

L.A. McKeown

January 13, 2011

News Daily News

NEJM Letters Take on PARTNER Trial

Caitlin E. Cox

January 11, 2011

News Daily News

Consensus TAVI Endpoint Definitions Raise Standard of Research in New Field

January 11, 2011

News Daily News

Year in Review: Highlights of 2010 Include Data on Valvular Therapy, CTA Progress

Caitlin E. Cox

January 02, 2011

News

PARTNER: All-Cause, CV Mortality Lower in Patients Treated with TAVI vs. Standard Therapy at 1 Year

TCT Daily Staff

September 23, 2010

News Industry News

Leading health organizations collaborate with industry on new initiative to combat growing diabetes and cardiovascular disease threat

News Industry News

Advertisement

FDA Advisory Panel to Review Edwards SAPIEN Valve on July 20

PARTNER Finds Higher Rate of Neurological Events with TAVI vs. Surgery

Single-Center Experience Shows Evolution of CoreValve Procedure Over Time

TAVI with CoreValve Effective, Safe at 2-Years, Though Mortality a Concern

ACC Scientific Session-i2 Summit 2011: The Devil Is in the Details

Study Focuses on Permanent Pacemaker Predictors in TAVI vs. Surgery

REMEDIAL II Trial of PLC's RenalGuard® Demonstrates Greater Efficacy than Current Standard of Care

PARTNER: TAVI Cost Effective Compared With Standard Care

PARTNER: In High-Risk Surgical Candidates, TAVI Proves Just as Effective

Edwards Lifesciences Achieves Primary Endpoint in Transcatheter Valve Study of High-Risk Surgical Patients

ESC: Newer Risk Scores May Be Needed for Predicting Mortality in Valve Disease

Different Factors Linked to Early, Late Mortality with CoreValve TAVI

NEJM Letters Take on PARTNER Trial

Consensus TAVI Endpoint Definitions Raise Standard of Research in New Field

Year in Review: Highlights of 2010 Include Data on Valvular Therapy, CTA Progress

PARTNER: All-Cause, CV Mortality Lower in Patients Treated with TAVI vs. Standard Therapy at 1 Year

Leading health organizations collaborate with industry on new initiative to combat growing diabetes and cardiovascular disease threat

Medtronic Drug-Coated Balloon (DCB) Demonstrates Consistent Results in Two New Analyses of Complex PAD Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content